Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Accelerated Approval vs Breakthrough Therapy

<< Previous

Bullboard Posts

Next >>

Comment by N0taP00pon Apr 19, 2023 11:41pm

126 Views

Post# 35404369

RE:Accelerated Approval vs Breakthrough Therapy

When you get posting diarrhea, it doesn't turn out well for the rest of us. There's;s other info being posted here that's actually relevant to Theralase. Like Plantrader said, maybe we're all spinning yarns to while away the time till we actually hear something.

<< Previous

Bullboard Posts

Next >>

Morning Market Outlook for Nov. 25, 2024